Market Tracker

04/27 4:42pm ET

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

127.88
Delayed Data
As of 4:00pm ET
 -5.32 / -3.99%
Today’s Change
62.41
Today|||52-Week Range
137.50
+7.64%
Year-to-Date

Today’s Trading

Previous close133.20
Today’s open134.09
Day’s range126.69 - 135.07
Volume2,252,296
Average volume (3 months)1,703,616
Market cap$32.2B
Dividend yield--
Data as of 4:00pm ET, 04/27/2015

Growth & Valuation

Earnings growth (last year)-58.59%
Earnings growth (this year)+52.34%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)-52.11%
P/E ratioNM
Price/Sales48.16
Price/Book29.96

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...-5.33-2.96%
MYLMylan NV-4.34-5.71%
PRGOPerrigo Company PLC-4.61-2.39%
ZTSZoetis Inc-1.08-2.25%
Data as of 4:02pm ET, 04/27/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)-$0.73
Annual revenue (last year)$580.4M
Annual profit (last year)-$738.6M
Net profit margin-127.09%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
SVP &
GM-International Commercial Operations
Simon Bedson
Corporate headquarters
Boston, Massachusetts

Forecasts